| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |